{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:06:53Z","timestamp":1789103213622,"version":"build-2803163510"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Parkinson's disease (PD) is increasingly recognized as a multisystem disorder in which gastrointestinal dysfunction and gut microbial alterations may contribute to disease pathophysiology. Although most microbiome research in PD has focused on bacteria, growing evidence suggests that the gut ecosystem should be considered more broadly to include fungi, viruses, metabolites, and proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed and SciFinder for human studies published up to October 28, 2025, using domain-specific search strategies for the bacteriome, metabolome, proteome, virome, and mycobiome, and synthesized the eligible evidence using a structured multi-omics evidence-mapping framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We summarize the most consistent bacterial findings, including enrichment of mucin-degrading taxa and depletion of short-chain fatty acid-producing commensals, and discuss how these changes relate to impaired fermentation, barrier dysfunction, and immune activation. We further examine emerging evidence for virome and mycobiome alterations, highlighting the possibility that PD-related dysbiosis reflects cross-kingdom ecological disruption rather than bacteria-only imbalance. Metabolomic studies provide functional support for this model by demonstrating altered short-chain fatty acid biology and broader host -microbe co-metabolic remodeling. Protein-focused studies, including host proteomic signatures and bacterial functional amyloids, extend the field toward mechanisms linking gut dysfunction to inflammation, proteostatic stress, and \u03b1-synuclein pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, the evidence supports a multi-layer view of the PD gut -brain axis in which microbial ecology, metabolic output, barrier integrity, immune signaling, and protein-centered mechanisms are interconnected. The field remains limited by cross-sectional designs, methodological heterogeneity, and uneven evidence depth across omics layers. Longitudinal, standardized, and integrated multi-omics studies will be essential to determine which microbiome-associated alterations are mechanistically important, clinically informative, and potentially modifiable in PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1900578","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:31:12Z","timestamp":1789101072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond bacteria: a multi-omics view of the gut\u2013brain axis in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Huiye","family":"Han","sequence":"first","affiliation":[{"name":"Department of Mathematics, University of Maryland","place":["College Park, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Luo","sequence":"additional","affiliation":[{"name":"Winston Churchill High School","place":["Potomac, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Maryland","place":["College Park, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyazana","family":"Rahaman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Maryland","place":["College Park, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Unbyul","family":"Ok","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Maryland","place":["College Park, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University","place":["Cleveland, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglu","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Maryland","place":["College Park, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Maryland","place":["College Park, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in parkinson\u2019s disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in parkinson\u2019s disease: temporal stability and relations to disease progression","volume":"44","author":"Aho","year":"2019","journal-title":"EBioMedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1152","article-title":"Faecal metabolite deficit, gut inflammation and diet in parkinson\u2019s disease: Integrative analysis indicates inflammatory response syndrome","volume":"13","author":"Augustin","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","article-title":"Effects of resistant starch on symptoms, fecal markers, and gut microbiota in parkinson\u2019s disease\u2014the resista-pd trial","volume":"20","author":"Becker","year":"2022","journal-title":"Genomics Proteomics Bioinf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage l-dopa-na\u00efve parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1101\/2022.07.20.500694","article-title":"Integrated multi-cohort analysis of the parkinson\u2019s disease gut metagenome","volume":"38","author":"Boktor","year":"2023","journal-title":"Movement Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"D352","DOI":"10.1093\/nar\/gkac882","article-title":"Amylograph: a comprehensive database of amyloid\u2013amyloid interactions","volume":"51","author":"Burdukiewicz","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000213592","article-title":"Investigating plasma metabolomics and gut microbiota changes associated with parkinson disease: a focus on caffeine metabolism","volume":"104","author":"Chen","year":"2025","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/jpd-223179","article-title":"Alteration of gut microbial metabolites in the systemic circulation of patients with parkinson\u2019s disease","volume":"12","author":"Chen","year":"2022","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glag001","article-title":"Alterations of the gut virome in patients with parkinson\u2019s disease","volume":"81","author":"Chen","year":"2026","journal-title":"Journals Gerontology: Ser. A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"19155","DOI":"10.1038\/s41598-023-45953-z","article-title":"A novel pathway of levodopa metabolism by commensal bifidobacteria","volume":"13","author":"Cirstea","year":"2023","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","article-title":"Microbiota composition and metabolism are associated with gut function in parkinson\u2019s disease","volume":"35","author":"Cirstea","year":"2020","journal-title":"Movement Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.005","article-title":"The faecal metabolome and mycobiome in parkinson\u2019s disease","volume":"95","author":"De Pablo-Fernandez","year":"2022","journal-title":"Parkinsonism related Disord."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70541","article-title":"Effect of probiotics supplementation on rem sleep behavior disorder and motor symptoms in parkinson\u2019s disease: a pilot study","volume":"31","author":"Du","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18906","DOI":"10.1038\/s41598-024-69742-4","article-title":"Metagenome-assembled microbial genomes from parkinson\u2019s disease fecal samples","volume":"14","author":"Duru","year":"2024","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early parkinson\u2019s disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-biochem-032620-105157","article-title":"Structural mimicry in microbial and antimicrobial amyloids","volume":"91","author":"Golan","year":"2022","journal-title":"Annu. Rev. Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","article-title":"An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of parkinson\u2019s disease participants","volume":"14","author":"Hall","year":"2023","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting parkinson\u2019s disease up to 7 years before symptom onset","volume":"15","author":"H\u00e4llqvist","year":"2024","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41598-025-29692-x","article-title":"Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in parkinson\u2019s disease: a randomized double-blind prospective study","volume":"16","author":"Hegelmaier","year":"2026","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Movement Disord."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2554195","article-title":"Metabolic modeling links gut microbiota to metabolic markers of parkinson\u2019s disease","volume":"17","author":"Hensen","year":"2025","journal-title":"Gut Microbes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i9.2759","article-title":"Fecal microbes, short chain fatty acids, and colorectal cancer across racial\/ethnic groups","volume":"21","author":"Hester","year":"2015","journal-title":"World J. gastroenterology: WJG"},{"key":"B26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Movement Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.immuni.2016.04.004","article-title":"Viral safeguard: the enteric virome protects against gut inflammation","volume":"44","author":"Karst","year":"2016","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","article-title":"Quantitative metabolomics of saliva using proton nmr spectroscopy in patients with parkinson\u2019s disease and healthy controls","volume":"41","author":"Kumari","year":"2020","journal-title":"Neurological Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-025-02095-w","article-title":"Distinct gut microbiome characteristics and dynamics in patients with parkinson\u2019s disease based on the presence of premotor rapid-eye movement sleep behavior disorders","volume":"13","author":"Lee","year":"2025","journal-title":"Microbiome"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1002\/mds.70047","article-title":"Effects of a four-strain probiotic on gut microbiota, inflammation, and symptoms in parkinson\u2019s disease: A randomized clinical trial","volume":"40","author":"Leta","year":"2025","journal-title":"Movement Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1007\/s10072-024-07641-2","article-title":"Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with parkinson\u2019s disease","volume":"45","author":"Liao","year":"2024","journal-title":"Neurological Sci."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with parkinson\u2019s disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1594152","article-title":"Anxiety-related gut microbiota alterations in parkinson\u2019s disease: distinct associations compared to healthy individuals","volume":"15","author":"Lin","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","article-title":"Gut microbiota in patients with parkinson\u2019s disease in southern China","volume":"53","author":"Lin","year":"2018","journal-title":"Parkinsonism related Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1038\/s41564-024-01858-9","article-title":"Coffee consumption is associated with intestinal lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts","volume":"9","author":"Manghi","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/ene.13398","article-title":"More than constipation\u2013bowel symptoms in parkinson\u2019s disease and their connection to gut microbiota","volume":"24","author":"Mertsalmi","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111661","article-title":"Role of microbiota-derived short-chain fatty acids in nervous system disorders","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","article-title":"Meta-analysis of gut dysbiosis in parkinson\u2019s disease","volume":"35","author":"Nishiwaki","year":"2020","journal-title":"Movement Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41531-024-00724-z","article-title":"Meta-analysis of shotgun sequencing of gut microbiota in parkinson\u2019s disease","volume":"10","author":"Nishiwaki","year":"2024","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.31222\/osf.io\/v7gm2","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"bmj"},{"key":"B41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ana.26719","article-title":"Metagenomics of the gut microbiome in parkinson\u2019s disease: prodromal changes","volume":"94","author":"Palacios","year":"2023","journal-title":"Ann. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41531-026-01271-5","article-title":"Metagenomics indicates an interplay of the microbiome and functional pathways in parkinson\u2019s disease","volume":"12","author":"Park","year":"2026","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"106217","DOI":"10.1016\/j.bbi.2025.106217","article-title":"Resistant starch improves parkinson\u2019s disease symptoms through restructuring of the gut microbiome and modulating inflammation","volume":"132","author":"Petrov","year":"2025","journal-title":"Brain Behavior Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of parkinson\u2019s patients","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Parkinsonism related Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","article-title":"Gut metagenomics-derived genes as potential biomarkers of parkinson\u2019s disease","volume":"143","author":"Qian","year":"2020","journal-title":"Brain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1039\/d2fo00552b","article-title":"Urolithins: potential biomarkers of gut dysbiosis and disease stage in parkinson\u2019s patients","volume":"13","author":"Romo-Vaquero","year":"2022","journal-title":"Food. Funct."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","article-title":"Plasma short-chain fatty acids in patients with parkinson\u2019s disease","volume":"35","author":"Shin","year":"2020","journal-title":"Movement Disord."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.836706","article-title":"Gut virome: role and distribution in health and gastrointestinal diseases","volume":"12","author":"Spencer","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"bmj"},{"key":"B51","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","article-title":"Gut microbial ecosystem in parkinson disease: new clinicobiological insights from multi-omics","volume":"89","author":"Tan","year":"2021","journal-title":"Ann. Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s42255-024-01044-5","article-title":"Interaction between the gut microbiota and colonic enteroendocrine cells regulates host metabolism","volume":"6","author":"Tan","year":"2024","journal-title":"Nat. Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1101\/305896","article-title":"Parkinson\u2019s disease and bacteriophages as its overlooked contributors","volume":"8","author":"Tetz","year":"2018","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13099-016-0109-1","article-title":"Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model","volume":"8","author":"Tetz","year":"2016","journal-title":"Gut Pathog."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02239","article-title":"Prion-like domains in phagobiota","volume":"8","author":"Tetz","year":"2017","journal-title":"Front. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40168-025-02227-2","article-title":"Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic parkinson\u2019s disease","volume":"13","author":"Villette","year":"2025","journal-title":"Microbiome"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","article-title":"Metagenomics of parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms","volume":"13","author":"Wallen","year":"2022","journal-title":"Nat. Commun."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106504118","article-title":"Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B59","first-page":"127","article-title":"Aggregating gut: on the link between neurodegeneration and bacterial functional amyloids","volume-title":"npj Biofilms Microbiomes","author":"Wojciechowska","year":"2024"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","article-title":"Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in parkinson\u2019s disease patients","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Neurol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1900578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:31:16Z","timestamp":1789101076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1900578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":60,"alternative-id":["10.3389\/fcimb.2026.1900578"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1900578","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1900578"}}